Eisai

Anonymous board for Eisai.
Post thread


Happy Pearl Harbor Day
Replies
2
Views
294
anonymous
Eisai sunsets development, access program for withdrawn obesity med in Dravet syndrome | Fierce Pharma
Replies
2
Views
334
anonymous
Eisai dials back forecasts for Alzheimer's drug Leqembi | pharmaphorum
Replies
5
Views
700
anonymous
EXEL Earnings Call
Replies
9
Views
755
anonymous
FierceBiotech: Eisai, Lilly Alzheimer’s trials withheld brain injury risk: NYT
Replies
11
Views
814
anonymous
You do not pay well in oncology.
Replies
8
Views
941
anonymous
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials - The New York Times
Replies
5
Views
546
anonymous
Australia Is Latest Country to Say 'No' to Leqembi | Being Patient
Replies
1
Views
204
anonymous
Leqembi and the Aussies
Replies
2
Views
318
anonymous
FiercePharma: Leqembi's vial design could result in hundreds of millions in annual Medicare waste: study
Replies
1
Views
336
anonymous
Happy at Eisai with neurology position
Replies
39
Views
7K
anonymous
What's the scoop on Bill McLean?
Replies
43
Views
17K
anonymous
Debate rages over Alzheimer’s drug lecanemab as UK limits approval
Replies
2
Views
360
anonymous
Endpoints: Eisai says Alzheimer's drug keeps working after three years. But weaknesses in study raise questions
Replies
8
Views
906
anonymous
Why are so many leaving recently and where is everyone going?
Replies
10
Views
2K
anonymous
Jennifer Simier
Replies
0
Views
419
anonymous
Novo’s GLP-1 drug liraglutide slows cognitive decline by 18% in mid-stage Alzheimer's study
Replies
1
Views
283
anonymous
European Medicines Agency rejects breakthrough Alzheimer’s drug
Replies
6
Views
760
anonymous
Join IT or pass
Replies
2
Views
312
anonymous
The end of the beginning: Lilly execs eye top spot in burgeoning Alzheimer's market after Kisunla's FDA approval | Fierce Pharma
Replies
5
Views
601
anonymous
Top Bottom
Back
Post thread